Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.

Systemic pharmacokinetics and safety of high doses of nebulized colistimethate sodium in critically ill patients with hospital-acquired and ventilator-associated pneumonia.

Benítez-Cano A, de Antonio-Cuscó M, Luque S, Sorlí L, Carazo J, Ramos I, Bermejo S, Campillo N, Horcajada JP, Samsó E, Grau S.

J Antimicrob Chemother. 2019 Sep 8. pii: dkz356. doi: 10.1093/jac/dkz356. [Epub ahead of print]

PMID:
31495877
2.

Linezolid versus glycopeptides in the treatment of glycopeptide-susceptible Enterococcus faecium bacteremia: A propensity-score matched comparative study.

Echeverria-Esnal D, Sorli L, Prim N, Conde-Estévez D, Mateu-De Antonio J, Martin-Ontiyuelo C, Horcajada JP, Grau S.

Int J Antimicrob Agents. 2019 Aug 30. pii: S0924-8579(19)30236-5. doi: 10.1016/j.ijantimicag.2019.08.018. [Epub ahead of print]

PMID:
31476435
3.

Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections.

Horcajada JP, Montero M, Oliver A, Sorlí L, Luque S, Gómez-Zorrilla S, Benito N, Grau S.

Clin Microbiol Rev. 2019 Aug 28;32(4). pii: e00031-19. doi: 10.1128/CMR.00031-19. Print 2019 Sep 18. Review.

PMID:
31462403
4.

Colistin for the treatment of urinary tract infections caused by extremely drug-resistant Pseudomonas aeruginosa: Dose is critical.

Sorlí L, Luque S, Li J, Campillo N, Danés M, Montero M, Segura C, Grau S, Horcajada JP.

J Infect. 2019 Sep;79(3):253-261. doi: 10.1016/j.jinf.2019.06.011. Epub 2019 Jun 29.

PMID:
31265867
5.

Linezolid dosing in patients with liver cirrhosis: Standard dosing risks toxicity.

Luque S, Muñoz-Bermudez R, Echeverría-Esnal D, Sorli L, Campillo N, Martínez-Casanova J, González-Colominas E, Álvarez-Lerma F, Horcajada JP, Grau S, Roberts JA.

Ther Drug Monit. 2019 Jun 26. doi: 10.1097/FTD.0000000000000665. [Epub ahead of print]

PMID:
31259884
6.

Colistin plus meropenem combination is synergistic in vitro against extensively drug-resistant Pseudomonas aeruginosa, including high-risk clones.

Montero MM, Domene Ochoa S, López-Causapé C, VanScoy B, Luque S, Sorlí L, Campillo N, Padilla E, Prim N, Segura C, Pomar V, Rivera A, Grau S, Ambrose PG, Oliver A, Horcajada JP.

J Glob Antimicrob Resist. 2019 May 30;18:37-44. doi: 10.1016/j.jgar.2019.04.012. [Epub ahead of print]

PMID:
31154007
7.

Oral and intravenous fosfomycin in complicated urinary tract infections.

López-Montesinos I, Horcajada JP.

Rev Esp Quimioter. 2019 May;32 Suppl 1:37-44. Review.

8.

The Different Microbial Etiology of Prosthetic Joint Infections according to Route of Acquisition and Time after Prosthesis Implantation, Including the Role of Multidrug-Resistant Organisms.

Benito N, Mur I, Ribera A, Soriano A, Rodríguez-Pardo D, Sorlí L, Cobo J, Fernández-Sampedro M, Del Toro MD, Guío L, Praena J, Bahamonde A, Riera M, Esteban J, Baraia-Etxaburu JM, Martínez-Alvarez J, Jover-Sáenz A, Dueñas C, Ramos A, Sobrino B, Euba G, Morata L, Pigrau C, Horcajada JP, Coll P, Crusi X, Ariza J; REIPI (Spanish Network for Research in Infectious Disease) Group for the Study of Prosthetic Joint Infections / GEIO (Group for the Study of Osteoarticular Infections), SEIMC (Spanish Society of Infectious Diseases and Clinical Microbiolo.

J Clin Med. 2019 May 13;8(5). pii: E673. doi: 10.3390/jcm8050673.

9.

Population Pharmacokinetics of Anidulafungin in Critically Ill Patients.

Luque S, Hope W, Campillo N, Muñoz-Bermúdez R, Sorli L, Barceló-Vidal J, González-Colominas E, Alvarez-Lerma F, Masclans JR, Montero M, Horcajada JP, Grau S.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e00378-19. doi: 10.1128/AAC.00378-19. Print 2019 Jul.

PMID:
31061150
10.

Colistin Use in Patients with Chronic Kidney Disease: Are We Underdosing Patients?

Sorli L, Luque S, Li J, Rodríguez E, Campillo N, Fernandez X, Soldado J, Domingo I, Montero M, Grau S, Horcajada JP.

Molecules. 2019 Feb 1;24(3). pii: E530. doi: 10.3390/molecules24030530.

11.

Economic evaluation of the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) from the national payer perspective: introduction of a new treatment to the patient journey. A simulation of three European countries.

Marcellusi A, Viti R, Sciattella P, Sarmati L, Streinu-Cercel A, Pana A, Espin J, Horcajada JP, Favato G, Andretta D, Soro M, Andreoni M, Mennini FS.

Expert Rev Pharmacoecon Outcomes Res. 2019 Oct;19(5):581-599. doi: 10.1080/14737167.2019.1569516. Epub 2019 Feb 4.

PMID:
30714834
12.

Risk of hospital readmission and associated factors after a positive sample for a multidrug-resistant microorganism.

Sentís A, González C, Montero M, Herranz M, Hidalgo C, Campà C, Sala M, Macià F, Román M, Prats-Uribe A, Horcajada JP, Castells X.

Eur J Public Health. 2018 Dec 24. doi: 10.1093/eurpub/cky262. [Epub ahead of print]

PMID:
30590519
13.

High-dose benznidazole in a 62-year-old Bolivian kidney transplant recipient with Chagas central nervous system involvement.

Montero M, Mir M, Sulleiro E, Avalos Esquivel JL, García López E, Molina-Morant D, López Montesinos I, Sorlí L, Veliz Espinosa G, Mounteis Oliva E, Crespo M, Monge I, Horcajada JP, Grau S, Pascual J.

Int J Infect Dis. 2019 Jan;78:103-106. doi: 10.1016/j.ijid.2018.10.014. Epub 2018 Oct 25.

14.

General Assembly, Treatment, Antimicrobials: Proceedings of International Consensus on Orthopedic Infections.

Boyle KK, Kuo FC, Horcajada JP, Hughes H, Cavagnaro L, Marculescu C, McLaren A, Nodzo SR, Riccio G, Sendi P, Silibovsky R, Stammers J, Tan TL, Wimmer M.

J Arthroplasty. 2019 Feb;34(2S):S225-S237. doi: 10.1016/j.arth.2018.09.074. Epub 2018 Oct 22. No abstract available.

PMID:
30360976
15.

Antimicrobial stewardship in Spain: Programs for Optimizing the use of Antibiotics (PROA) in Spanish hospitals.

Horcajada JP, Grau S, Paño-Pardo JR, López A, Oliver A, Cisneros JM, Rodriguez-Baño J.

Germs. 2018 Sep 3;8(3):109-112. doi: 10.18683/germs.2018.1137. eCollection 2018 Sep. No abstract available.

16.

Relationship Between Biofilm Formation and Antimicrobial Resistance in Gram-Negative Bacteria.

Cepas V, López Y, Muñoz E, Rolo D, Ardanuy C, Martí S, Xercavins M, Horcajada JP, Bosch J, Soto SM.

Microb Drug Resist. 2019 Jan/Feb;25(1):72-79. doi: 10.1089/mdr.2018.0027. Epub 2018 Aug 24.

PMID:
30142035
17.

Evaluation of Ceftolozane-Tazobactam in Combination with Meropenem against Pseudomonas aeruginosa Sequence Type 175 in a Hollow-Fiber Infection Model.

Montero M, VanScoy BD, López-Causapé C, Conde H, Adams J, Segura C, Zamorano L, Oliver A, Horcajada JP, Ambrose PG.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e00026-18. doi: 10.1128/AAC.00026-18. Print 2018 May.

18.

Impact of an antimicrobial stewardship program on urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.

Esteve-Palau E, Grau S, Herrera S, Sorlí L, Montero M, Segura C, Durán X, Horcajada JP.

Rev Esp Quimioter. 2018 Apr;31(2):110-117. Epub 2018 Mar 9.

19.

Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial.

Kaye KS, Bhowmick T, Metallidis S, Bleasdale SC, Sagan OS, Stus V, Vazquez J, Zaitsev V, Bidair M, Chorvat E, Dragoescu PO, Fedosiuk E, Horcajada JP, Murta C, Sarychev Y, Stoev V, Morgan E, Fusaro K, Griffith D, Lomovskaya O, Alexander EL, Loutit J, Dudley MN, Giamarellos-Bourboulis EJ.

JAMA. 2018 Feb 27;319(8):788-799. doi: 10.1001/jama.2018.0438.

20.

Trends in AIDS Mortality, Retention in Opioid Agonist Therapy, and HIV RNA Suppression in HIV-Infected People Who Injected Drugs from 2000 to 2015.

Vallecillo G, Robles MJ, Durán X, Lerma E, Horcajada JP, Torrens M.

AIDS Behav. 2018 Sep;22(9):2766-2772. doi: 10.1007/s10461-018-2033-5.

PMID:
29372455
21.

A Before-and-After Study of the Effectiveness of an Antimicrobial Stewardship Program in Critical Care.

Álvarez-Lerma F, Grau S, Echeverría-Esnal D, Martínez-Alonso M, Gracia-Arnillas MP, Horcajada JP, Masclans JR.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e01825-17. doi: 10.1128/AAC.01825-17. Print 2018 Apr.

22.

Metabolomic Profile of ARDS by Nuclear Magnetic Resonance Spectroscopy in Patients With H1N1 Influenza Virus Pneumonia.

Izquierdo-Garcia JL, Nin N, Jimenez-Clemente J, Horcajada JP, Arenas-Miras MDM, Gea J, Esteban A, Ruiz-Cabello J, Lorente JA.

Shock. 2018 Nov;50(5):504-510. doi: 10.1097/SHK.0000000000001099.

PMID:
29293175
23.

Erratum for del Barrio-Tofiño et al., "Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain".

Del Barrio-Tofiño E, López-Causapé C, Cabot G, Rivera A, Benito N, Segura C, Montero MM, Sorlí L, Tubau F, Gómez-Zorrilla S, Tormo N, Durá-Navarro R, Viedma E, Resino-Foz E, Fernández-Martínez M, González-Rico C, Alejo-Cancho I, Martínez JA, Labayru-Echverria C, Dueñas C, Ayestarán I, Zamorano L, Martinez-Martinez L, Horcajada JP, Oliver A.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e02352-17. doi: 10.1128/AAC.02352-17. Print 2018 Jan. No abstract available.

24.

Virulence genes and subclone status as markers of experimental virulence in a murine sepsis model among Escherichia coli sequence type 131 clinical isolates from Spain.

Merino I, Porter SB, Johnston BD, Clabots C, Shaw E, Horcajada JP, Cantón R, Ruiz-Garbajosa P, Johnson JR; ITUBRAS-GEIH group.

PLoS One. 2017 Nov 30;12(11):e0188838. doi: 10.1371/journal.pone.0188838. eCollection 2017.

25.

Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain.

Del Barrio-Tofiño E, López-Causapé C, Cabot G, Rivera A, Benito N, Segura C, Montero MM, Sorlí L, Tubau F, Gómez-Zorrilla S, Tormo N, Durá-Navarro R, Viedma E, Resino-Foz E, Fernández-Martínez M, González-Rico C, Alejo-Cancho I, Martínez JA, Labayru-Echverria C, Dueñas C, Ayestarán I, Zamorano L, Martinez-Martinez L, Horcajada JP, Oliver A.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e01589-17. doi: 10.1128/AAC.01589-17. Print 2017 Nov. Erratum in: Antimicrob Agents Chemother. 2017 Dec 21;62(1):.

26.

Discriminant biomarkers of acute respiratory distress syndrome associated to H1N1 influenza identified by metabolomics HPLC-QTOF-MS/MS platform.

Ferrarini A, Righetti L, Martínez MP, Fernández-López M, Mastrangelo A, Horcajada JP, Betbesé A, Esteban A, Ordóñez J, Gea J, Cabello JR, Pellati F, Lorente JA, Nin N, Rupérez FJ.

Electrophoresis. 2017 Sep;38(18):2341-2348. doi: 10.1002/elps.201700112. Epub 2017 Aug 25.

PMID:
28714069
27.

Multinational case-control study of risk factors for the development of late invasive pulmonary aspergillosis following kidney transplantation.

López-Medrano F, Fernández-Ruiz M, Silva JT, Carver PL, van Delden C, Merino E, Pérez-Saez MJ, Montero M, Coussement J, de Abreu Mazzolin M, Cervera C, Santos L, Sabé N, Scemla A, Cordero E, Cruzado-Vega L, Martín-Moreno PL, Len Ó, Rudas E, Ponce de León A, Arriola M, Lauzurica R, David MD, González-Rico C, Henríquez-Palop F, Fortún J, Nucci M, Manuel O, Paño-Pardo JR, Montejo M, Vena A, Sánchez-Sobrino B, Mazuecos A, Pascual J, Horcajada JP, Lecompte T, Moreno A, Carratalà J, Blanes M, Hernández D, Hernández-Méndez EA, Fariñas MC, Perelló-Carrascosa M, Muñoz P, Andrés A, Aguado JM; Spanish Network for Research in Infectious Diseases (REIPI); Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC); Study Group for Infections in Compromised Hosts (ESGICH) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID); Swiss Transplant Cohort Study (STCS).

Clin Microbiol Infect. 2018 Feb;24(2):192-198. doi: 10.1016/j.cmi.2017.06.016. Epub 2017 Jun 23.

28.

High-dose daptomycin together with rifampin as salvage therapy for prosthetic joint infections.

Herrera S, Sorlí L, Horcajada JP.

Med Clin (Barc). 2017 Sep 8;149(5):223-224. doi: 10.1016/j.medcli.2017.04.031. Epub 2017 Jun 8. English, Spanish. No abstract available.

PMID:
28602211
29.

Urinary Concentrations of Colistimethate and Formed Colistin after Intravenous Administration in Patients with Multidrug-Resistant Gram-Negative Bacterial Infections.

Luque S, Escaño C, Sorli L, Li J, Campillo N, Horcajada JP, Salas E, Grau S.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e02595-16. doi: 10.1128/AAC.02595-16. Print 2017 Aug.

30.

Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial.

Villar-García J, Güerri-Fernández R, Moya A, González A, Hernández JJ, Lerma E, Guelar A, Sorli L, Horcajada JP, Artacho A, D Auria G, Knobel H.

PLoS One. 2017 Apr 7;12(4):e0173802. doi: 10.1371/journal.pone.0173802. eCollection 2017.

31.

The Not-So-Good Prognosis of Streptococcal Periprosthetic Joint Infection Managed by Implant Retention: The Results of a Large Multicenter Study.

Lora-Tamayo J, Senneville É, Ribera A, Bernard L, Dupon M, Zeller V, Li HK, Arvieux C, Clauss M, Uçkay I, Vigante D, Ferry T, Iribarren JA, Peel TN, Sendi P, Miksic NG, Rodríguez-Pardo D, Del Toro MD, Fernández-Sampedro M, Dapunt U, Huotari K, Davis JS, Palomino J, Neut D, Clark BM, Gottlieb T, Trebše R, Soriano A, Bahamonde A, Guío L, Rico A, Salles MJC, Pais MJG, Benito N, Riera M, Gómez L, Aboltins CA, Esteban J, Horcajada JP, O'Connell K, Ferrari M, Skaliczki G, Juan RS, Cobo J, Sánchez-Somolinos M, Ramos A, Giannitsioti E, Jover-Sáenz A, Baraia-Etxaburu JM, Barbero JM, Choong PFM, Asseray N, Ansart S, Moal GL, Zimmerli W, Ariza J; Group of Investigators for Streptococcal Prosthetic Joint Infection .

Clin Infect Dis. 2017 Jun 15;64(12):1742-1752. doi: 10.1093/cid/cix227.

32.

C-reactive protein may misdiagnose prosthetic joint infections, particularly chronic and low-grade infections.

Pérez-Prieto D, Portillo ME, Puig-Verdié L, Alier A, Martínez S, Sorlí L, Horcajada JP, Monllau JC.

Int Orthop. 2017 Jul;41(7):1315-1319. doi: 10.1007/s00264-017-3430-5. Epub 2017 Mar 21.

PMID:
28321490
33.

Executive summary of management of prosthetic joint infections. Clinical practice guidelines by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC).

Ariza J, Cobo J, Baraia-Etxaburu J, Benito N, Bori G, Cabo J, Corona P, Esteban J, Horcajada JP, Lora-Tamayo J, Murillo O, Palomino J, Parra J, Pigrau C, Del Pozo JL, Riera M, Rodríguez D, Sánchez-Somolinos M, Soriano A, Del Toro MD, de la Torre B; Spanish Network for the Study of Infectious Diseases and the Sociedad Española de Enfermedades Infecciosas; Microbiología Clínica (SEIMC).

Enferm Infecc Microbiol Clin. 2017 Mar;35(3):189-195. doi: 10.1016/j.eimc.2016.08.012. Epub 2017 Feb 16. English, Spanish.

PMID:
28215487
34.

Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonate.

Horcajada JP, Sorlí L, Luque S, Benito N, Segura C, Campillo N, Montero M, Esteve E, Mirelis B, Pomar V, Cuquet J, Martí C, Garro P, Grau S.

Int J Antimicrob Agents. 2016 Dec;48(6):725-727. doi: 10.1016/j.ijantimicag.2016.08.020. Epub 2016 Oct 7.

PMID:
28128096
35.

Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosa.

Sorlí L, Luque S, Segura C, Campillo N, Montero M, Esteve E, Herrera S, Benito N, Alvarez-Lerma F, Grau S, Horcajada JP.

BMC Infect Dis. 2017 Jan 5;17(1):11. doi: 10.1186/s12879-016-2117-7.

36.

Daptomycin use: where is the truth? Authors' response.

Echeverría-Esnal D, Grau S, Horcajada JP.

Future Microbiol. 2017 Jan;12:13-14. doi: 10.2217/fmb-2016-0199. Epub 2016 Dec 6. No abstract available.

PMID:
27922754
37.

Preoperative antibiotic prophylaxis in prosthetic joint infections: not a concern for intraoperative cultures.

Pérez-Prieto D, Portillo ME, Puig-Verdié L, Alier A, Gamba C, Guirro P, Martínez-Díaz S, Horcajada JP, Trampuz A, Monllau JC.

Diagn Microbiol Infect Dis. 2016 Dec;86(4):442-445. doi: 10.1016/j.diagmicrobio.2016.09.014. Epub 2016 Sep 23.

PMID:
27745737
38.

Clinical Presentation and Determinants of Mortality of Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: A Multinational Cohort Study.

López-Medrano F, Fernández-Ruiz M, Silva JT, Carver PL, van Delden C, Merino E, Pérez-Saez MJ, Montero M, Coussement J, de Abreu Mazzolin M, Cervera C, Santos L, Sabé N, Scemla A, Cordero E, Cruzado-Vega L, Martín-Moreno PL, Len Ó, Rudas E, de León AP, Arriola M, Lauzurica R, David M, González-Rico C, Henríquez-Palop F, Fortún J, Nucci M, Manuel O, Paño-Pardo JR, Montejo M, Muñoz P, Sánchez-Sobrino B, Mazuecos A, Pascual J, Horcajada JP, Lecompte T, Moreno A, Carratalà J, Blanes M, Hernández D, Fariñas MC, Andrés A, Aguado JM; Spanish Network for Research in Infectious Diseases (REIPI), the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC), the Study Group for Infections in Compromised Hosts (ESGICH) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), and the Swiss Transplant Cohort Study (STCS).

Am J Transplant. 2016 Nov;16(11):3220-3234. doi: 10.1111/ajt.13837. Epub 2016 May 31.

39.

Validation Protocol of Vitamin D Supplementation in Patients with HIV-Infection.

Lerma-Chippirraz E, Güerri-Fernández R, Villar García J, González Mena A, Guelar Grinberg A, Montero MM, Sorli L, Calzado S, Horcajada JP, Díez-Pérez A, Knobel Freud H.

AIDS Res Treat. 2016;2016:5120831. Epub 2016 Sep 6.

40.

Short- versus long-duration levofloxacin plus rifampicin for acute staphylococcal prosthetic joint infection managed with implant retention: a randomised clinical trial.

Lora-Tamayo J, Euba G, Cobo J, Horcajada JP, Soriano A, Sandoval E, Pigrau C, Benito N, Falgueras L, Palomino J, Del Toro MD, Jover-Sáenz A, Iribarren JA, Sánchez-Somolinos M, Ramos A, Fernández-Sampedro M, Riera M, Baraia-Etxaburu JM, Ariza J; Prosthetic Joint Infection Group of the Spanish Network for Research in Infectious Diseases—REIPI.

Int J Antimicrob Agents. 2016 Sep;48(3):310-6. doi: 10.1016/j.ijantimicag.2016.05.021. Epub 2016 Aug 3.

PMID:
27524103
41.

CTX-M-15-H30Rx-ST131 subclone is one of the main causes of healthcare-associated ESBL-producing Escherichia coli bacteraemia of urinary origin in Spain.

Merino I, Shaw E, Horcajada JP, Cercenado E, Mirelis B, Pallarés MA, Gómez J, Xercavins M, Martínez-Martínez L, De Cueto M, Cantón R, Ruiz-Garbajosa P; ITUBRAS-GEIH-SEIMC Group.

J Antimicrob Chemother. 2016 Aug;71(8):2125-30. doi: 10.1093/jac/dkw133. Epub 2016 May 12.

PMID:
27494832
42.

IFITM3 and severe influenza virus infection. No evidence of genetic association.

López-Rodríguez M, Herrera-Ramos E, Solé-Violán J, Ruíz-Hernández JJ, Borderías L, Horcajada JP, Lerma-Chippirraz E, Rajas O, Briones M, Pérez-González MC, García-Bello MA, López-Granados E, Rodriguez de Castro F, Rodríguez-Gallego C.

Eur J Clin Microbiol Infect Dis. 2016 Nov;35(11):1811-1817. Epub 2016 Aug 4.

PMID:
27492307
43.

Urinary micafungin levels are sufficient to treat urinary tract infections caused by Candida spp.

Grau S, Luque S, Echeverría-Esnal D, Sorlí L, Campillo N, Montero M, Álvarez Lerma F, Plasencia V, Horcajada JP.

Int J Antimicrob Agents. 2016 Aug;48(2):212-4. doi: 10.1016/j.ijantimicag.2016.05.010. Epub 2016 Jul 5.

PMID:
27424599
44.

An antimicrobial stewardship program reduces antimicrobial therapy duration and hospital stay in surgical wards.

Güerri-Fernández R, Villar-García J, Herrera-Fernández S, Trenchs-Rodríguez M, Fernández-Morato J, Moro L, Sancho J, Grande L, Clará A, Grau S, Horcajada JP.

Rev Esp Quimioter. 2016 Jun;29(3):119-21. Epub 2016 May 11.

45.

Characterization and rapid control of a vancomycin-resistant Enterococcus faecium (VREF) outbreak in a renal transplant unit in Spain: The environment matters.

Herrera S, Sorlí L, Pérez-Sáez MJ, Ruiz-Garbajosa P, Barrios C, Plasencia V, Montero M, Terradas R, Crespo M, Castells X, Cantón R, Pascual J, Horcajada JP.

Enferm Infecc Microbiol Clin. 2017 Jan;35(1):5-11. doi: 10.1016/j.eimc.2016.04.002. Epub 2016 May 5.

PMID:
27156245
46.

Drug treatments for prosthetic joint infections in the era of multidrug resistance.

Perez-Jorge C, Gomez-Barrena E, Horcajada JP, Puig-Verdie L, Esteban J.

Expert Opin Pharmacother. 2016 Jun;17(9):1233-46. doi: 10.1080/14656566.2016.1176142. Epub 2016 May 4. Review.

PMID:
27054293
47.

Brief Report: HIV Infection Is Associated With Worse Bone Material Properties, Independently of Bone Mineral Density.

Güerri-Fernández R, Molina D, Villar-García J, Prieto-Alhambra D, Mellibovsky L, Nogués X, González-Mena A, Guelar A, Trenchs-Rodríguez M, Herrera-Fernández S, Horcajada JP, Díez-Pérez A, Knobel H.

J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):314-8. doi: 10.1097/QAI.0000000000000965.

PMID:
26910501
48.

Enterococcal bloodstream infection. Design and validation of a mortality prediction rule.

Pérez-García A, Landecho MF, Beunza JJ, Conde-Estévez D, Horcajada JP, Grau S, Gea A, Mauleón E, Sorli L, Gómez J, Terradas R, Lucena JF, Alegre F, Huerta A, Del Pozo JL.

Int J Clin Pract. 2016 Feb;70(2):147-55. doi: 10.1111/ijcp.12754.

PMID:
26817569
49.

Risk Factors Associated With Early Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: Results From a Multinational Matched Case-Control Study.

López-Medrano F, Silva JT, Fernández-Ruiz M, Carver PL, van Delden C, Merino E, Pérez-Saez MJ, Montero M, Coussement J, de Abreu Mazzolin M, Cervera C, Santos L, Sabé N, Scemla A, Cordero E, Cruzado-Vega L, Martín-Moreno PL, Len Ó, Rudas E, de León AP, Arriola M, Lauzurica R, David M, González-Rico C, Henríquez-Palop F, Fortún J, Nucci M, Manuel O, Paño-Pardo JR, Montejo M, Muñoz P, Sánchez-Sobrino B, Mazuecos A, Pascual J, Horcajada JP, Lecompte T, Lumbreras C, Moreno A, Carratalà J, Blanes M, Hernández D, Hernández-Méndez EA, Fariñas MC, Perelló-Carrascosa M, Morales JM, Andrés A, Aguado JM; Spanish Network for Research in Infectious Diseases (REIPI), the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC), the Study Group for Infections in Compromised Hosts (ESGICH) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), and the Swiss Transplant Cohort Study (STCS).

Am J Transplant. 2016 Jul;16(7):2148-57. doi: 10.1111/ajt.13735. Epub 2016 Mar 10.

50.

Clinical characteristics, treatment and outcomes of MRSA bacteraemia in the elderly.

Cuervo G, Gasch O, Shaw E, Camoez M, Domínguez MÁ, Padilla B, Pintado V, Almirante B, Lepe JA, López-Medrano F, Ruiz de Gopegui E, Martínez JA, Montejo JM, Perez-Nadales E, Arnáiz A, Goenaga MÁ, Benito N, Horcajada JP, Rodríguez-Baño J, Pujol M; REIPI/GEIH study group.

J Infect. 2016 Mar;72(3):309-16. doi: 10.1016/j.jinf.2015.12.009. Epub 2015 Dec 24.

PMID:
26723914

Supplemental Content

Loading ...
Support Center